Organon & Co. (OGN)
Organon & Co. - Organon Provides Update on Phase 2 ELENA Proof-of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain
Abeona Therapeutics Inc. (ABEO)
Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million
Organon & Co. (OGN)
Organon Provides Update on Phase 2 ELENA Proof-of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain
Ligand Pharmaceuticals Incorporated (LGNYZ)
Invivyd Inc (IVVD)
Tonix Pharmaceuticals Holding Corp (TNXP)
Astrana Health Inc (ASTH)
New Form 8-K - Astrana Health, Inc. Filed: 2025-07-02 AccNo: 0001104659-25-065009 Size: 243 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Bausch Health Companies Inc (BHC)
Bausch Health Notification
Invivyd Inc (IVVD)
Invivyd and Leading Researchers Form SPEAR (Spike Protein Elimination and Recovery) Study Group to Assess the Effects of Monoclonal Antibody Therapy for Long COVID and COVID-19 Post-Vaccination Syndrome
TScan Therapeutics Inc. (TCRX)
Astrana Health Inc (ASTH)
Astrana Health Announces Closing of Prospect Health Acquisition
Shattuck Labs Inc (STTK)
Shattuck Labs - Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism
Green Thumb Industries Inc. (GTBIF)
Green Thumb Industries to Hold Second Quarter 2025 Earnings Conference Call on August 6, 2025
Tonix Pharmaceuticals Holding Corp (TNXP)
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in Cancer Cell Journal Highlighting Positive Preclinical Data of mTNX-1700 in Gastric Cancer Animal Models
Ligand Pharmaceuticals Incorporated (LGND)
Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics